Iantrek website screenshot

Iantrek

Iantrek, Inc. is a venture-backed ophthalmic medical technology company headquartered in White Plains, New York, pioneering the field it calls bio-interventional ophthalmic surgery (BIOS) for the treatment of glaucoma. Founded in 2019 by ophthalmic innovator Sean Ianchulev, MD, MPH, the company develops micro-interventional surgical devices that reinforce and restore the eye's natural aqueous outflow pathways with biologic allograft tissue rather than bypassing or removing tissue. Its commercial and pipeline portfolio includes AlloFlo Uveo, AlloSert Uveo, C-Rex and AlloSpan Canal. Iantrek has raised approximately $103M across its rounds, including a $42M Series C used to launch AlloFlo Uveo in the United States in October 2025. Iantrek publishes a corporate and surgeon-facing marketing website at iantrekmed.com; it operates no public developer portal, documentation, or machine-readable API surface.

Iantrek is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Ophthalmology, and Glaucoma.

Iantrek’s developer surface includes product news, support, and 15 more developer resources.

🌐 Visit website 📡 Source on GitHub
12.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesHealth CareOphthalmologyGlaucomaSurgeryMedical TechnologyLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 12.4/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.7 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/iantrek: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Iantrek Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization
GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Learn 1

Tutorials, courses, talks, and written guidance

Videos
Videos

Operate 2

Status, limits, changes, and where to get help

Contact
Contact
 Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 5

The organization behind the API

Website
Website
 About
About
 News
News
 Careers
Careers
 LinkedIn
LinkedIn

Other 4

Properties that don't map to a standard resource type

Products
Products
 Products
Products
 Products
Products
 Testimonials
Testimonials

Source (apis.yml)

apis.yml Raw ↑ 
aid: iantrek
name: Iantrek
description: Iantrek, Inc. is a venture-backed ophthalmic medical technology company headquartered in White Plains, New York,
  pioneering the field it calls bio-interventional ophthalmic surgery (BIOS) for the treatment of glaucoma. Founded in 2019
  by ophthalmic innovator Sean Ianchulev, MD, MPH, the company develops micro-interventional surgical devices that reinforce
  and restore the eye's natural aqueous outflow pathways with biologic allograft tissue rather than bypassing or removing
  tissue. Its commercial and pipeline portfolio includes AlloFlo Uveo, AlloSert Uveo, C-Rex and AlloSpan Canal. Iantrek has
  raised approximately $103M across its rounds, including a $42M Series C used to launch AlloFlo Uveo in the United States
  in October 2025. Iantrek publishes a corporate and surgeon-facing marketing website at iantrekmed.com; it operates no public
  developer portal, documentation, or machine-readable API surface.
image: https://cdn.prod.website-files.com/68a8587a72d95eb3c8e82014/68af21a8c819016c8870130b_Graph%20Card.png
url: https://raw.githubusercontent.com/api-evangelist/iantrek/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: enriched-no-api-surface
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Medical Devices
- Health Care
- Ophthalmology
- Glaucoma
- Surgery
- Medical Technology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://iantrekmed.com/
- type: About
  url: https://iantrekmed.com/about
- type: Products
  name: AlloFlo Uveo
  url: https://iantrekmed.com/alloflo
- type: Products
  name: AlloSert Uveo
  url: https://iantrekmed.com/allosert
- type: Products
  name: C-Rex
  url: https://iantrekmed.com/crex
- type: Testimonials
  url: https://iantrekmed.com/testimonials
- type: Videos
  name: Surgical Videos
  url: https://iantrekmed.com/surgical-videos
- type: News
  url: https://iantrekmed.com/news
- type: Contact
  url: https://iantrekmed.com/contact
- type: Support
  url: https://iantrekmed.com/contact-v1
- type: Careers
  url: https://iantrekmed.com/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/iantrek-inc/
- type: GitHubOrganization
  url: https://github.com/iantrek
- type: PrivacyPolicy
  url: https://iantrekmed.com/privacy-policy
- type: TermsOfService
  url: https://iantrekmed.com/terms-of-service
- type: DomainSecurity
  url: security/iantrek-domain-security.yml
- type: LLMsTxt
  url: llms/iantrek-llms.txt
x-enrichment:
  date: '2026-08-04'
  status: nochange
  artifacts_added: 0
  pass: local-v1
  note: 'Second pass — independently re-verified, no API surface found and no new artifact was produced. Contract discovery
    re-probed iantrekmed.com and www.iantrekmed.com for /openapi.json, /openapi.yaml, /swagger.json, /v1/openapi.json, /api-docs,
    /docs, /redoc, /api, /graphql, /llms.txt, /sitemap.xml and every /.well-known/ path including both A2A agent-card paths
    (/.well-known/agent-card.json and the legacy /.well-known/agent.json): all 36 probes returned HTTP 404. api./developer./docs./portal./status./trust./app./dev./mcp./agent./data./cdn.
    subdomains are all NXDOMAIN. iantrek.com is not first-party (unrelated parked host returning a service-provider error
    page). Zero packages on npm, PyPI, RubyGems, crates.io, NuGet and Packagist. The first-party GitHub org github.com/iantrek
    (created 2024-04-24) holds one repository, .github, carrying only a profile README. probe-security-programs.py returned
    vdp=none trust=none, so no vulnerability-disclosure or trust-center artifact was written. The site is a 16-page Webflow
    marketing and surgeon-facing site. Iantrek is a medical-device manufacturer; no agent card, MCP server, or specification
    was authored on its behalf. This pass added only real published product/content pointers (AlloSert Uveo, C-Rex, Testimonials,
    Surgical Videos) to common[].'